XBIOTECH INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
XBIOTECH INC. (XBIT) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$1.10 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2022-03-15
- XBIOTECH INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was -$1.10M, a 122.92% decline from fiscal 2020.
- XBIOTECH INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $4.80M.
- XBIOTECH INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2019 was -$45.60M, a 1853.85% decline from fiscal 2018.
- XBIOTECH INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2018 was $2.60M, a 50.94% decline from fiscal 2017.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2021-12-31 | -$1.10M 10-K · filed 2022-03-15 | |
| 2020-12-31 | $4.80M 10-K · filed 2022-03-15 | |
| 2019-12-31 | -$45.60M 10-K · filed 2021-03-16 | |
| 2018-12-31 | $2.60M 10-K · filed 2020-03-16 | $2.70M 10-K · filed 2019-03-14 |
| 2017-12-31 | $5.30M 10-K/A · filed 2019-03-15 | |
| 2016-12-31 | $11.50M 10-K · filed 2018-03-16 | |
| 2015-12-31 | $10.30M 10-K · filed 2017-03-16 | |
| 2014-12-31 | $9.40M 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |